Verbatim response from ChatGPT
Short answer: No — you should not be using compounded tirzepatide. Legitimate, approved tirzepatide is available only as the brand products from Eli Lilly (Mounjaro for type 2 diabetes and Zepbound for weight management). Compounded versions are unapproved, often unsafe, and have been the subject of FDA and state pharmacy warnings.
Why:
- Tirzepatide is an engineered peptide/biologic. Compounding bypasses FDA review for purity, potency, sterility and stability. That raises real safety risks (wrong dose, contamination, degraded product).
- The FDA and many state boards have warned against pharmacies compounding tirzepatide or selling unapproved copies; pharmacies that claim to routinely compound brand drugs or make “cheap” copies may be operating illegally or unsafely.
What to do instead:
- Talk with your prescriber about an appropriate FDA‑approved product (Mounjaro or Zepbound) and have it filled at a licensed pharmacy or specialty pharmacy (examples include CVS Specialty, Accredo/Express Scripts Specialty, Walgreens Specialty, Optum/UnitedHealth specialty services). These pharmacies handle storage, prior authorization, and manufacturer support properly.
- If cost/insurance is a barrier, ask your clinician about manufacturer patient‑support programs and co‑pay savings from Eli Lilly, or search Lilly’s patient assistance resources. Your prescriber or specialty pharmacy can help with prior authorizations.
- If you’re looking for alternative access, consider enrolling in a legitimate clinical trial (search clinicaltrials.gov) rather than buying compounded product from the gray market.
- If you encounter a pharmacy or website selling compounded tirzepatide, report it to your state board of pharmacy and/or to the FDA (MedWatch).
I can help you find legitimate specialty pharmacies that work with your insurer or locate patient‑assistance information from Lilly if you want — tell me your state/insurance situation (no personal medical details needed) and I’ll point you to appropriate resources.